Akari Therapeutics

Akari Therapeutics

Developing bi-functional antibody drug conjugates for cancer.

HQ location
Walton-on-Thames, United Kingdom
Launch date
Employees
Market cap
$26.3m
Enterprise value
$25m
Share price
$0.81 AKTX
Company register number
Recent deals
Authorizing premium user...